Details
Description
The purpose of this analysis was to describe the baseline characteristics and duration of follow-up time among new users of 24 new molecular entities (NMEs) approved in 2008 and 25 NMEs approved in 2009 by the U.S. Food and Drug Administration in the Sentinel Distributed Database (SDD). We distributed this request to 17 Data Partners on January 25, 2019.
This analysis contains two reports:
- Report 1: This report contains data on users of NMEs approved in 2008. The study period included data from January 1, 2008 to June 30, 2018.
- Report 2: This report contains data on users of NMEs approved in 2009.The study period included data from January 1, 2009 to June 30, 2018.